Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

70 results
Display

Hypertriglyceridemia Is an Independent Risk Factor for Cardiovascular Diseases in Korean Adults Aged 30–49 Years: a Nationwide Population-Based Study

Koo BK, Park S, Han KD, Moon MK

Objective: This study was conducted to estimate the incidence of cardiovascular disease (CVD) independently from low-density lipoprotein (LDL) cholesterol according to triglyceride (TG) levels in young adults. Methods: Subjects aged 30–49...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Long-Term Sodium-Glucose Cotransporter 2 Inhibitor Treatment on Renal Function in Patients with Type 2 Diabetes

Baek JH, Oh TJ, Moon JY, Kim T, Ko SH, Moon MK, Kim HJ, Lee DW, Hur KY, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology

Chronic kidney disease commonly develops in patients with type 2 diabetes mellitus (T2DM) and is the most common cause of end-stage renal disease and related cardiovascular complications. Meanwhile, despite the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: a Korean Diabetes Association and Korean Society of Nephrology consensus statement

Oh TJ, Moon JY, Hur KY, Ko SH, Kim HJ, Kim T, Lee DW, Moon MK, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology

Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Long-term Sodium-glucose Cotransporter 2 Inhibitor Treatment on Renal Function in the Patients with Type 2 Diabetes

Baek JH, Oh TJ, Moon JY, Kim T, Ko SH, Moon MK, Kim HJ, Lee DW, Hur KY

Chronic kidney disease is developed commonly in type 2 diabetes mellitus (T2DM) and is the most common cause of end-stage renal disease and related cardiovascular complications. Meanwhile, despite the current...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Electric Stimulation Hyperthermia Relieves Inflammation via the Suppressor of Cytokine Signaling 3-Toll Like Receptor 4 Pathway in a Prostatitis Rat Model

Zhu GQ, Jeon SH, Lee KW, Tian WJ, Cho HJ, Ha US, Hong SH, Lee JY, Moon MK, Moon SH, Kim SW, Bae WJ

Purpose: Chronic prostatitis (CP), including chronic pelvic pain syndrome (CPPS), is the most commonly encountered manifestation of prostatitis. The aim of this study was to evaluate the effect of electric...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
2018 Guidelines for the Management of Dyslipidemia in Korea

Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, Song Y, Lim JH, Kim HJ, Choi S, Moon MK, Na JO, Park KY, Oh MS, Han SY, Noh J, Yi KH, Lee SH, Hong SC, Jeong IK, On behalf of the Committee of Clinical Practice Guideline of Korean Society of Lipid and Atherosclerosis

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum: 2018 Guidelines for the management of dyslipidemia in Korea

Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, Song Y, Lim JH, Kim HJ, Choi S, Moon MK, Na JO, Park KY, Oh MS, Han SY, Noh J, Yi KH, Lee SH, Hong SC, Jeong IK, Committee of Clinical Practice Guideline of Korean Society of Lipid and Atherosclerosis

The title and author names are incorrect.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea

Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, Park SO, Hur KY, Chon S, Moon MK, Kim NH, Kim SY, Rhee SY, Lee KW, Kim JH, Rhee EJ, Chun S, Yu SH, Kim DJ, Kwon HS, Park KS, Committee of Clinical Practice Guidelines, Korean Diabetes Association

The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
2018 Guidelines for the management of dyslipidemia

Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, Song Y, Lim JH, Kim HJ, Choi S, Moon MK, Na JO, Park KY, Oh MS, Han SY, Noh J, Yi KH, Lee SH, Hong SC, Jeong IK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-fasting triglyceride levels in the Korean population with and without ischemic heart disease and cerebrovascular disease

Lee SY, Koo BK, Moon MK

BACKGROUND/AIMS: Associations between non-fasting triglyceride (TG) levels and a risk of ischemic heart disease (IHD) and cerebrovascular accident (CVA) have been suggested in Caucasians. We aimed to investigate whether non-fasting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concern about the Safety of Bisphenol A Substitutes

Moon MK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7)

Kong SH, Koo BK, Moon MK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus

Kong SH, Koo BK, Moon MK

BACKGROUND: The study aimed to evaluate the effects of dapagliflozin and metformin on vascular endothelial function and renal injury markers. METHODS: This prospective, randomized, open-label, crossover study included drug-naïve patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice

Hong AR, Koo BK, Kim SW, Yi KH, Moon MK

BACKGROUND: This study aimed to evaluate the efficacy and safety of sodium-glucose cotransporter-2 (SGLT2) inhibitors in Korean patients who had inadequately controlled type 2 diabetes mellitus (T2DM) in real-world clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus

Moon MK

The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus (T2DM). In combination therapy of oral hypoglycemic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improvement of Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus under Insulin Treatment by Reimbursement for Self-Monitoring of Blood Glucose

Song YS, Koo BK, Kim SW, Yi KH, Shin K, Moon MK

BACKGROUND: In Korea, the costs associated with self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes mellitus (T2DM) under insulin treatment have been reimbursed since November 2015. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of a Telephone-Based Self-management Program Led by Nurses on Self-care Behavior, Biological Index for Cardiac Function, and Depression in Ambulatory Heart Failure Patients

Moon MK, Yim J, Jeon MY

PURPOSE: This study was conducted to examine the effects of a telephone-based self-management support program led by nurses on self-care behavior, biological index for cardiac function, and depression. METHODS: This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prediction of Coronary Heart Disease Risk in Korean Patients with Diabetes Mellitus

Koo BK, Oh S, Kim YJ, Moon MK

OBJECTIVE: We developed a new equation for predicting coronary heart disease (CHD) risk in Korean diabetic patients using a hospital-based cohort and compared it with a UK Prospective Diabetes Study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30)

Kong SH, Koo BK, Moon MK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus

Kong SH, Koo BK, Moon MK

BACKGROUND: There has been evidences of ethnic differences in the low density lipoprotein cholesterol (LDL-C) lowering effect of statin. We aimed to evaluate the efficacy of moderate-intensity statins in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr